Wecare Probiotics Bifidobacterium animalis subsp. lactis BLa80 has a significant cholesterol-lowering effect and can alleviate the increase in high cholesterol caused by high-fat diet

Gut microbiota promote human gastrointestinal health, and the disruption of gut microbiota is related to the occurrence and development of many diseases. Supplementing probiotics is a commonly method for altering the gut microbiota to improve health. However, there is no clear literature on the impact of probiotics on the gut microbiota of healthy adults.

The Healthy China initiative is showing promising results, with the nation's health metrics on the rise. Central to this progress is the launch of the Wecare Probiotics Phase III Strain Factory, a testament to the burgeoning domestic probiotics industry's vitality.

A new milestone in the probiotic industry was achieved as Wecare Probiotics' Phase III factory in Wujiang, Suzhou, commenced operations with an annual output of 600 tons of probiotic powder.

Inflammatory bowel disease (IBD), whose clinical manifestations include ulcerative colitis (UC), affects the health of the intestinal tract, leads to frequent diarrhea, abdominal cramps, and rectal bleeding.

The intricate relationship between the gut microbiome and drug efficacy is gaining attention in the pharmaceutical industry, as highlighted during NutraIngredients' 2024 Probiota event.